MART-1(100-116)

Melanoma antigen recognized by T-cells 1; MART-1

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-037

Synonyms/Alias:Melanoma antigen recognized by T-cells 1 (100-116);MART-1(100-116)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
APPAYEKLSAEQSPPPY
Areas of Interest
Antigen-presenting Cells; Cancer Research

MART-1(100-116) is a synthetic peptide fragment derived from the melanoma antigen recognized by T cells 1 (MART-1), also known as Melan-A. As a defined epitope corresponding to residues 100 to 116 of the MART-1 protein, this peptide represents a critical sequence for immunological recognition in melanoma research. Its well-characterized structure and immunogenic properties make it a valuable reagent for studies focused on antigen processing, T cell activation, and tumor immunology. The peptide's sequence specificity and relevance to melanoma-associated antigens have established it as an important tool in the investigation of cellular immune responses and antigen presentation mechanisms.

Epitope mapping: Researchers utilize MART-1(100-116) to map antigenic determinants recognized by T cells, particularly within the context of melanoma immunology. By exposing immune cells to this defined peptide, investigators can identify and characterize the specific T cell receptors (TCRs) that interact with the MART-1 epitope, facilitating a deeper understanding of immune specificity and cross-reactivity. This mapping is vital for elucidating the molecular basis of immune recognition, which informs the design of immunological assays and experimental models.

T cell activation assays: The peptide is frequently employed in functional assays to stimulate and measure the activation of MART-1-specific T lymphocytes. In vitro systems using peripheral blood mononuclear cells (PBMCs) or isolated T cells enable quantitative assessment of cytokine production, proliferation, and cytotoxicity in response to antigen exposure. These assays are instrumental in evaluating the potency and specificity of T cell responses, supporting both basic research and the development of experimental immunotherapeutic strategies.

Antigen presentation studies: MART-1(100-116) serves as a model substrate for investigating the mechanisms of peptide processing and major histocompatibility complex (MHC) class II presentation. Researchers use the peptide to load antigen-presenting cells (APCs) and study the efficiency of peptide-MHC binding, stability, and presentation to CD4+ T cells. Insights gained from these studies contribute to the broader understanding of immune surveillance, antigen processing pathways, and the modulation of immune responses in the tumor microenvironment.

Immunomonitoring tools: In experimental settings, the peptide is incorporated into immunomonitoring protocols to detect and quantify antigen-specific T cells in blood or tissue samples. Techniques such as enzyme-linked immunospot (ELISPOT) assays, intracellular cytokine staining, and multimer staining utilize the peptide to track the frequency and functional status of MART-1-reactive T cells. These tools are essential for evaluating immune responses in preclinical models and for monitoring immune reactivity in translational research contexts.

Peptide-based assay development: The defined sequence and immunological relevance of MART-1(100-116) make it a preferred standard in the development and validation of peptide-based laboratory assays. Its use supports the optimization of protocols for peptide synthesis, purification, and functional testing. Additionally, the peptide provides a benchmark for assay sensitivity and specificity, ensuring reproducibility and reliability in experimental workflows focused on antigen-specific immune recognition.

Source#
Homo sapiens (human)
Epitope
100-116
Restricting HLA
HLA-DRA/DRB1
References
Yili Li; J Mol Biol 2010

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesisCustom Conjugation ServiceEpitope Mapping ServicesPeptide Modification ServicesPeptide Synthesis ServicesPeptide Analysis ServicesPeptide CDMOcGMP Peptide Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers